{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T10:50:46Z","timestamp":1745491846015},"reference-count":77,"publisher":"Media Sphere Publishing House","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2019]]},"DOI":"10.17116\/jnevro20191191275","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T11:50:53Z","timestamp":1555501853000},"page":"75","source":"Crossref","is-referenced-by-count":2,"special_numbering":"Vyp. 2","title":["Addictophobia in modern psychiatry (benzodiazepines and other psychopharmacological drugs)"],"prefix":"10.17116","volume":"119","author":[{"given":"V. D.","family":"Mendelevich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro20191191275-1","unstructured":"Avedisova AS, Borodin VI. From noncompliance to rejection of psychopharmacotherapy. Psikhiatriya i Psikhofarmakoterapiya. 2005;6:316-318. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-2","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20151154259-63"},{"key":"key-10.17116\/jnevro20191191275-3","unstructured":"Mendelevich VD. Psychiatric spectrum disorders and problem of therapeutic relativism. Nevrologicheskii Vestnik. 2017;4:11-20. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-4","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S133513"},{"key":"key-10.17116\/jnevro20191191275-5","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S158443"},{"key":"key-10.17116\/jnevro20191191275-6","unstructured":"Blansfield HN. Addictophobia. Conn Med. 1991;55(6):361."},{"key":"key-10.17116\/jnevro20191191275-7","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20169"},{"key":"key-10.17116\/jnevro20191191275-8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i574"},{"key":"key-10.17116\/jnevro20191191275-9","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2018118123-9"},{"key":"key-10.17116\/jnevro20191191275-10","doi-asserted-by":"publisher","DOI":"10.1177\/0004867416644980"},{"key":"key-10.17116\/jnevro20191191275-11","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109106915"},{"key":"key-10.17116\/jnevro20191191275-12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.104257"},{"key":"key-10.17116\/jnevro20191191275-13","unstructured":"Avedisova AS, Yastrebov DV. Prolonged use of benzodiazal tranquilizers: the prevalence and association with the formation of drug dependence. Psikhiatriya i Psikhofarmakoterapiya. 2010;1:17-25. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-14","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201611611218-23"},{"key":"key-10.17116\/jnevro20191191275-15","unstructured":"Mikhailova OI. Zloupotreblenie benzodiazepinovymi trankvilizatorami pri pogranichnykh psikhicheskikh rasstroistvakh (obzor literatury): Dis... kand. med. nauk. M. 2007. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-16","unstructured":"Cheberda OA. Osobennosti bol'nykh, dlitel'no prinimayushchikh benzodiazepinovye trankvilizatory v ambulatornoi psikhiatricheskoi praktike: Dis... kand. med. nauk. M. 2006. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-17","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2015.055"},{"key":"key-10.17116\/jnevro20191191275-18","doi-asserted-by":"crossref","unstructured":"Buth S, Hoizbach R, Rosenkranz M, Verthein U. The use of prescription drugs with dependence potential in Germany: a prospective analysis of prescriptions in the public healthcare system between 2006 and 2010. Bundesgusundeheitsblatt Gesundenheitsforschung Gesundenheitsschutz. 2017;60(8):865-872.","DOI":"10.1007\/s00103-017-2571-4"},{"key":"key-10.17116\/jnevro20191191275-19","doi-asserted-by":"crossref","unstructured":"Cha HJ, Lee KW, Eom J.H. Kim Y.-H, Shin J, Yun J, Han K, Kim HS. 5-(2-Aminopropyl) benzofuran and phenazepam demonstrate the possibility of dependence by increasing dopamine levels in the brain. Pharmacol Biochem Behav. 2016;149:17-22.","DOI":"10.1016\/j.pbb.2016.08.002"},{"key":"key-10.17116\/jnevro20191191275-20","unstructured":"Corci F, Mansueto G, Faccini M, Casari R, Lugoboni F. Sociodemografic and clinical characteristics of benzodiazepine long-term users: results from a tertiary care center. Compr Psychiatry. 2016;96:211-215."},{"key":"key-10.17116\/jnevro20191191275-21","doi-asserted-by":"publisher","DOI":"10.1080\/01634372.2014.901470"},{"key":"key-10.17116\/jnevro20191191275-22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd009652.pub2"},{"key":"key-10.17116\/jnevro20191191275-23","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s83130"},{"key":"key-10.17116\/jnevro20191191275-24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd005194.pub2"},{"key":"key-10.17116\/jnevro20191191275-25","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-017-0128-4"},{"key":"key-10.17116\/jnevro20191191275-26","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2369-1"},{"key":"key-10.17116\/jnevro20191191275-27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7020017"},{"key":"key-10.17116\/jnevro20191191275-28","unstructured":"Avedisova AS. On the issue of dependence on benzodiazepines. Psikhiatriya i Psikhofarmakoterapiya. 1999;1:12-15. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-29","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2015.0001"},{"key":"key-10.17116\/jnevro20191191275-30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.09.003"},{"key":"key-10.17116\/jnevro20191191275-31","unstructured":"Lader M. Long-term anxiolytic therapy: the issue of drug withdrawal. J Clin Psychiatry. 1987;48:12-16."},{"key":"key-10.17116\/jnevro20191191275-32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142057"},{"key":"key-10.17116\/jnevro20191191275-33","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-015-0090-x"},{"key":"key-10.17116\/jnevro20191191275-34","unstructured":"Mengue N, Abdous B, Bertiche D, Preville M, Voyer P. Benzodiazepine dependence and the risk of depression and anxiety disorders: seniors health study. Encephale. 2014;40(3):216-222."},{"key":"key-10.17116\/jnevro20191191275-35","unstructured":"NIDA Notes Staff. Well-known mechanism underlies benzodiazepines' addictive properties. NIDA Notes. 2012;24:7-11."},{"key":"key-10.17116\/jnevro20191191275-36","unstructured":"O'Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66(2):28-33."},{"key":"key-10.17116\/jnevro20191191275-37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02364"},{"key":"key-10.17116\/jnevro20191191275-38","doi-asserted-by":"crossref","unstructured":"Schmitz A. Benzodiazepine use, misuse, and abuse: A review. Ment Health Clin. 2016;6(3):120-126.","DOI":"10.9740\/mhc.2016.05.120"},{"key":"key-10.17116\/jnevro20191191275-39","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16br02025"},{"key":"key-10.17116\/jnevro20191191275-40","unstructured":"The misuse of benzodiazepines among high-risk opioid users in Europe. http:\/\/www.emcdda.europa.eu\/topics\/pods\/benzodiazepines"},{"key":"key-10.17116\/jnevro20191191275-41","unstructured":"Weaver MF. Prescription Sedative Misuse and Abuse. Yale J Biol Med. 2015;88(3):247-256."},{"key":"key-10.17116\/jnevro20191191275-42","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X691865"},{"key":"key-10.17116\/jnevro20191191275-43","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.1763"},{"key":"key-10.17116\/jnevro20191191275-44","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20151157147-59"},{"key":"key-10.17116\/jnevro20191191275-45","unstructured":"Poluektov MG. Concerning the Possibility of Long-Term Hypnotic Use. Effektivnaya Farmakoterapiya. 2016;19:60-66. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-46","unstructured":"Sivolap YuP. Silent addiction: hypnotic drug abuse. Effektivnaya Farmakoterapiya. 2014;22:30-34. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-47","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.3805"},{"key":"key-10.17116\/jnevro20191191275-48","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.83.9.1300"},{"key":"key-10.17116\/jnevro20191191275-49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1611832"},{"key":"key-10.17116\/jnevro20191191275-50","unstructured":"Differential approach to pharmacotherapy of anxiety disorders. Effektivnaya farmakoterapiya. Nevrologiya i Psikhiatriya. 2011;1:70-75. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-51","unstructured":"Vorobyova OV. Benzodiazepines: from skepticism to a rational (weighted) positions. Psikhiatriya i Psikhofarmakoterapiya im. P.B. Gannushkina. 2015;4:19-24. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-52","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20219"},{"key":"key-10.17116\/jnevro20191191275-53","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S37917"},{"key":"key-10.17116\/jnevro20191191275-54","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000143"},{"key":"key-10.17116\/jnevro20191191275-55","doi-asserted-by":"publisher","DOI":"10.1177\/026988119901300321"},{"key":"key-10.17116\/jnevro20191191275-56","unstructured":"Gullen E, Lepine JP. Does addiction to antidepressants exist? About a case of one addiction to tianeptine. Encephale. 2003;29(5):456-459."},{"key":"key-10.17116\/jnevro20191191275-57","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s167538"},{"key":"key-10.17116\/jnevro20191191275-58","unstructured":"Mu\u0308ller H, Seifert F, Maler J-M, Kornhuber J, Sperling W. Agomelatine reduces craving in benzodiazepine addict. Singapore M Case Reported J. 2012;53(11):e228."},{"key":"key-10.17116\/jnevro20191191275-59","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1429403"},{"key":"key-10.17116\/jnevro20191191275-60","doi-asserted-by":"publisher","DOI":"10.1080\/23311908.2016.1223902"},{"key":"key-10.17116\/jnevro20191191275-61","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0375-4"},{"key":"key-10.17116\/jnevro20191191275-62","unstructured":"Krupitsky EM, Burakov AM. Dependence on tianptine: case report. Narkologiya. 2007;1:73-75. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-63","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2018.1438687"},{"key":"key-10.17116\/jnevro20191191275-64","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6730a2"},{"key":"key-10.17116\/jnevro20191191275-65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018956"},{"key":"key-10.17116\/jnevro20191191275-66","unstructured":"Krupitskii EM. Use of anticonvulsants without a doctor's prescription: dependence syndrome or self-treatment? Manage pain. 2016;2:11-12. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-67","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.08.430"},{"key":"key-10.17116\/jnevro20191191275-68","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-122392"},{"key":"key-10.17116\/jnevro20191191275-69","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2013.06.008"},{"key":"key-10.17116\/jnevro20191191275-70","unstructured":"Ivanova NA. Sudebno-meditsinskaya ekspertiza smertel'nykh otravlenii klozapinom: Dis... kand. med. nauk. M. 2015. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-71","unstructured":"Bekker RA, Bykov YuV. Fenazepam to be reviewed again: An Israeli-Russian view. Psikhiatriya i Psikhofarmakoterapiya im. P.B. Gannushkina. 2017;5:15-24. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-72","doi-asserted-by":"crossref","unstructured":"Nenasteva AYu. Phenazepam: to the question of the efficacy and safety of benzodiazepine derivatives. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2017;12:156-161. (In Russ.)","DOI":"10.17116\/jnevro2017117121156-160"},{"key":"key-10.17116\/jnevro20191191275-73","unstructured":"Osadshiy YuYu, Voblenko RA, Archakov DS, Tarakanova EA. Benzodiazepines. An attempt to arrive at an informed consensus. Sovremennaya Terapiya Psikhicheskikh Rasstroistv. 2016;1:2-10. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-74","unstructured":"Seredenin SB, Voronina TA, Neznamov GG, Zherdev VP. Fenazepam: 25 let v meditsinskoi praktike. M.: Nauka; 2007. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-75","unstructured":"Syunyakov TS, Dorofeeva OA. Phenazepam: from effects to underlying mechanisms (review). Psikhicheskie Rasstroistva v Obshchei Meditsine. 2013;3:40-46. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-76","unstructured":"Sunyakov SA, Teleshova ES. Phenazepam is the effective benzodiazepine anxiolytic, used in therapy of borderline psychiatric disorders. Psikhiatriya i Psikhofarmakoterapiya. 2013;6:42-47. (In Russ.)"},{"key":"key-10.17116\/jnevro20191191275-77","unstructured":"Etingof AM. Phenazepam: modern view on the efficacy and safety. Farmateka. 2014;18(291):27-31. (In Russ.)."}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T15:51:25Z","timestamp":1574524285000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova-2\/2019\/1\/downloads\/ru\/1199772982019012075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["jnevro20191191275"],"URL":"https:\/\/doi.org\/10.17116\/jnevro20191191275","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}